Introduction to Low Dose Naltrexone (LDN)
Thursday 24 March at 7pm via Zoom
Our next workshop sees us welcome the founder of the LDN Research Trust, Linda Elsegood. We have invited Linda to present on the subject of LDN, as our LDN Choices booklet is not only the most downloaded booklet, it is also the most visited page on our website.
Linda will be giving us an introduction to LDN, how it works and her own personal experiences of using the treatment. LDN has been used in the USA to treat symptoms of autoimmune conditions, including MS since 1985 and is now used throughout Europe and around the world.
LDN is used ‘off label’ as a treatment for the symptoms of many conditions including Crohn’s disease, fibromyalgia, chronic fatigue syndrome and ulcerative colitis, all conditions with an autoimmune origin.
Naltrexone is thought to inhibit endorphins (the body’s natural painkiller). It is believed by inhibiting endorphins, the body reacts by producing more. This increase in endorphins reduces pain and increases a sense of wellbeing.
The presentation will cover the following points;
- Introduction to LDN
- How it works
- How people can obtain it on prescription
- Clinical trials
- Useful resources
- Question and Answers
The session aims to provide you with information on how LDN could be used to help manage your MS symptoms. For more information please visit our website to download our LDN Choices booklet.
If you can’t make the session live, don’t worry as we will be recording the presentation and will make it available to watch again for all those registering in advance.
We have a suggested donation of £5 for this information session, but you can make a donation of your choosing from £1 to attend.
If you would like to know more about this session or would like help registering, please email firstname.lastname@example.org.
In October 2003, Linda was diagnosed with secondary progressive MS and told there was nothing anyone could do to help. In December 2003, Linda started LDN and it was life-changing for her and in February 2004, she foundered the LDN Research Trust, which became a registered Charity in 2004.
LDN had such a significant impact on her life that she wanted to help other people not only with MS, but all autoimmune diseases, cancers, mental health issues, etc. So far, the charity has helped over a million people worldwide.
The LDN research Trust own LDN Radio Show, which listeners can access on Mixcloud, Captivate FM, Google, Apple & Amazon Podcast, iTunes and Spotify in addition to our Vimeo and YouTube channels.
They have made six documentaries, arrange LDN conferences both large and small, and host seminars in conjunction with pharmacies. In short, the LDN Research Trust strives to spread the word about LDN and to encourage and support ongoing research about the Low Dose Naltrexone.